BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beurel E. Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases. Front Mol Neurosci 2011;4:18. [PMID: 21941466 DOI: 10.3389/fnmol.2011.00018] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang Q, Dwivedi Y. Transcriptional profiling of mitochondria associated genes in prefrontal cortex of subjects with major depressive disorder. World J Biol Psychiatry 2017;18:592-603. [PMID: 27269743 DOI: 10.1080/15622975.2016.1197423] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
2 Bhavsar SK, Merches K, Bobbala D, Lang F. AKT/SGK-sensitive phosphorylation of GSK3 in the regulation of L-selectin and perforin expression as well as activation induced cell death of T-lymphocytes. Biochem Biophys Res Commun 2012;425:6-12. [PMID: 22814108 DOI: 10.1016/j.bbrc.2012.07.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
3 Jiang X, Zhou J, Wang Y, Chen L, Duan Y, Huang J, Liu C, Chen Y, Liu W, Sun H, Feng F, Qu W. Rational design and biological evaluation of a new class of thiazolopyridyl tetrahydroacridines as cholinesterase and GSK-3 dual inhibitors for Alzheimer’s disease. European Journal of Medicinal Chemistry 2020;207:112751. [DOI: 10.1016/j.ejmech.2020.112751] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wu Y, Wang L, Hu K, Yu C, Zhu Y, Zhang S, Shao A. Mechanisms and Therapeutic Targets of Depression After Intracerebral Hemorrhage. Front Psychiatry 2018;9:682. [PMID: 30618863 DOI: 10.3389/fpsyt.2018.00682] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
5 Hung S, Chung H, Luo S, Chu Y, Chen Y, Macdonald IJ, Chien S, Kotha P, Yang L, Hwang L, Dun NJ, Chuang D, Chen Y. Electroacupuncture improves TBI dysfunction by targeting HDAC overexpression and BDNF-associated Akt/GSK-3β signaling. Front Cell Neurosci 2022;16:880267. [DOI: 10.3389/fncel.2022.880267] [Reference Citation Analysis]
6 Medina-Rodriguez EM, Lowell JA, Worthen RJ, Syed SA, Beurel E. Involvement of Innate and Adaptive Immune Systems Alterations in the Pathophysiology and Treatment of Depression. Front Neurosci 2018;12:547. [PMID: 30174579 DOI: 10.3389/fnins.2018.00547] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
7 Koriyama Y, Nakayama Y, Matsugo S, Sugitani K, Ogai K, Takadera T, Kato S. Anti-inflammatory effects of lipoic acid through inhibition of GSK-3β in lipopolysaccharide-induced BV-2 microglial cells. Neurosci Res. 2013;77:87-96. [PMID: 23892131 DOI: 10.1016/j.neures.2013.07.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
8 Arab HH, Safar MM, Shahin NN. Targeting ROS-Dependent AKT/GSK-3β/NF-κB and DJ-1/Nrf2 Pathways by Dapagliflozin Attenuates Neuronal Injury and Motor Dysfunction in Rotenone-Induced Parkinson's Disease Rat Model. ACS Chem Neurosci 2021;12:689-703. [PMID: 33543924 DOI: 10.1021/acschemneuro.0c00722] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
9 Rom S, Dykstra H, Zuluaga-Ramirez V, Reichenbach NL, Persidsky Y. miR-98 and let-7g* protect the blood-brain barrier under neuroinflammatory conditions. J Cereb Blood Flow Metab 2015;35:1957-65. [PMID: 26126865 DOI: 10.1038/jcbfm.2015.154] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 8.7] [Reference Citation Analysis]
10 Pantović-stefanović M, Petronijević N, Dunjić-kostić B, Velimirović M, Nikolić T, Jurišić V, Lačković M, Damjanović A, Totić-poznanović S, Jovanović AA, Ivković M. sVCAM-1, sICAM-1, TNF-α and IL-6 levels in bipolar disorder type I: Acute, longitudinal and therapeutic implications. The World Journal of Biological Psychiatry 2018;19:S41-51. [DOI: 10.1080/15622975.2016.1259498] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
11 Tuttolomondo A, Puleo MG, Velardo MC, Corpora F, Daidone M, Pinto A. Molecular Biology of Atherosclerotic Ischemic Strokes. Int J Mol Sci 2020;21:E9372. [PMID: 33317034 DOI: 10.3390/ijms21249372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Samsom JN, Wong AH. Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models. Front Psychiatry 2015;6:13. [PMID: 25762938 DOI: 10.3389/fpsyt.2015.00013] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
13 Thota RN, Rosato JI, Burrows TL, Dias CB, Abbott KA, Martins RN, Garg ML. Docosahexaenoic Acid-Rich Fish Oil Supplementation Reduces Kinase Associated with Insulin Resistance in Overweight and Obese Midlife Adults. Nutrients 2020;12:E1612. [PMID: 32486256 DOI: 10.3390/nu12061612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Arredondo SB, Reyes DT, Herrera-Soto A, Mardones MD, Inestrosa NC, Varela-Nallar L. Andrographolide promotes hippocampal neurogenesis and spatial memory in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease. Sci Rep 2021;11:22904. [PMID: 34824314 DOI: 10.1038/s41598-021-01977-x] [Reference Citation Analysis]
15 Maixner DW, Weng HR. The Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain. J Pharm Pharmacol (Los Angel) 2013;1:001. [PMID: 25309941 DOI: 10.13188/2327-204X.1000001] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
16 Libro R, Giacoppo S, Bramanti P, Mazzon E. Is the Wnt/β-catenin pathway involved in the anti-inflammatory activity of glucocorticoids in spinal cord injury? Neuroreport 2016;27:1086-94. [PMID: 27513198 DOI: 10.1097/WNR.0000000000000663] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Libro R, Bramanti P, Mazzon E. The role of the Wnt canonical signaling in neurodegenerative diseases. Life Sci 2016;158:78-88. [PMID: 27370940 DOI: 10.1016/j.lfs.2016.06.024] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 13.8] [Reference Citation Analysis]
18 Guedes VA, Lai C, Devoto C, Edwards KA, Mithani S, Sass D, Vorn R, Qu BX, Rusch HL, Martin CA, Walker WC, Wilde EA, Diaz-Arrastia R, Gill JM, Kenney K. Extracellular Vesicle Proteins and MicroRNAs Are Linked to Chronic Post-Traumatic Stress Disorder Symptoms in Service Members and Veterans With Mild Traumatic Brain Injury. Front Pharmacol 2021;12:745348. [PMID: 34690777 DOI: 10.3389/fphar.2021.745348] [Reference Citation Analysis]
19 Yu Z, Ono C, Aiba S, Kikuchi Y, Sora I, Matsuoka H, Tomita H. Therapeutic concentration of lithium stimulates complement C3 production in dendritic cells and microglia via GSK-3 inhibition. Glia 2015;63:257-70. [PMID: 25179772 DOI: 10.1002/glia.22749] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
20 Cahlíková L, Macáková K, Benešová N, Chlebek J, Hošťálková A, Opletal L. Natural Compounds (Small Molecules) as Potential and Real Drugs of Alzheimer's Disease. Elsevier; 2014. pp. 153-94. [DOI: 10.1016/b978-0-444-63281-4.00006-9] [Cited by in Crossref: 8] [Article Influence: 1.0] [Reference Citation Analysis]
21 Dohare P, Cheng B, Ahmed E, Yadala V, Singla P, Thomas S, Kayton R, Ungvari Z, Ballabh P. Glycogen synthase kinase-3β inhibition enhances myelination in preterm newborns with intraventricular hemorrhage, but not recombinant Wnt3A. Neurobiol Dis 2018;118:22-39. [PMID: 29940337 DOI: 10.1016/j.nbd.2018.06.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
22 Mao K, Zhang G. The role of PARP1 in neurodegenerative diseases and aging. FEBS J. [DOI: 10.1111/febs.15716] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
23 Flintoff J, Kesby JP, Siskind D, Burne TH. Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential. Expert Opin Investig Drugs 2021;30:877-91. [PMID: 34213981 DOI: 10.1080/13543784.2021.1951702] [Reference Citation Analysis]
24 Stefanović MP, Petronijević N, Dunjić-Kostić B, Velimirović M, Nikolić T, Jurišić V, Lačković M, Damjanović A, Totić-Poznanović S, Jovanović AA, Ivković M. Role of sICAM-1 and sVCAM-1 as biomarkers in early and late stages of schizophrenia. J Psychiatr Res 2016;73:45-52. [PMID: 26679764 DOI: 10.1016/j.jpsychires.2015.11.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
25 Morris G, Berk M, Klein H, Walder K, Galecki P, Maes M. Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome. Mol Neurobiol 2017;54:4271-91. [PMID: 27339878 DOI: 10.1007/s12035-016-9975-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 7.8] [Reference Citation Analysis]
26 Pláteník J, Fišar Z, Buchal R, Jirák R, Kitzlerová E, Zvěřová M, Raboch J. GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression. Prog Neuropsychopharmacol Biol Psychiatry 2014;50:83-93. [PMID: 24334212 DOI: 10.1016/j.pnpbp.2013.12.001] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 8.7] [Reference Citation Analysis]
27 Cheng Y, Pardo M, Armini RS, Martinez A, Mouhsine H, Zagury JF, Jope RS, Beurel E. Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior. Brain Behav Immun 2016;53:207-22. [PMID: 26772151 DOI: 10.1016/j.bbi.2015.12.012] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 13.0] [Reference Citation Analysis]
28 Catanzaro G, Filardi T, Sabato C, Vacca A, Migliaccio S, Morano S, Ferretti E. Tissue and circulating microRNAs as biomarkers of response to obesity treatment strategies. J Endocrinol Invest 2021;44:1159-74. [PMID: 33111214 DOI: 10.1007/s40618-020-01453-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
29 Noori T, Dehpour AR, Sureda A, Fakhri S, Sobarzo-Sanchez E, Farzaei MH, Küpeli Akkol E, Khodarahmi Z, Hosseini SZ, Alavi SD, Shirooie S. The role of glycogen synthase kinase 3 beta in multiple sclerosis. Biomed Pharmacother 2020;132:110874. [PMID: 33080467 DOI: 10.1016/j.biopha.2020.110874] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Eyre H, Baune BT. Neuroimmunomodulation in unipolar depression: a focus on chronobiology and chronotherapeutics. J Neural Transm (Vienna) 2012;119:1147-66. [PMID: 22653515 DOI: 10.1007/s00702-012-0819-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
31 Jiang X, Wang Y, Liu C, Xing C, Wang Y, Lyu W, Wang S, Li Q, Chen T, Chen Y, Feng F, Liu W, Sun H. Discovery of potent glycogen synthase kinase 3/cholinesterase inhibitors with neuroprotection as potential therapeutic agent for Alzheimer’s disease. Bioorganic & Medicinal Chemistry 2021;30:115940. [DOI: 10.1016/j.bmc.2020.115940] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Vallée A, Vallée J, Guillevin R, Lecarpentier Y. Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis. Cell Mol Neurobiol 2018;38:783-95. [DOI: 10.1007/s10571-017-0550-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
33 Del Fabbro L, de Gomes MG, Souza LC, Goes AR, Boeira SP, Oliveira MS, Furian AF, Jesse CR. Chrysin suppress immune responses and protects from experimental autoimmune encephalomyelitis in mice. Journal of Neuroimmunology 2019;335:577007. [DOI: 10.1016/j.jneuroim.2019.577007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
34 L'Episcopo F, Tirolo C, Serapide MF, Caniglia S, Testa N, Leggio L, Vivarelli S, Iraci N, Pluchino S, Marchetti B. Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain. Front Aging Neurosci 2018;10:12. [PMID: 29483868 DOI: 10.3389/fnagi.2018.00012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 9.3] [Reference Citation Analysis]
35 García-García R, Martín-Herrero L, Blanca-Pariente L, Pérez-Cabello J, Roodveldt C. Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Int J Mol Sci 2021;22:13280. [PMID: 34948077 DOI: 10.3390/ijms222413280] [Reference Citation Analysis]
36 Silva MR, Correia AO, dos Santos GCA, Parente LLT, de Siqueira KP, Lima DGS, Moura JA, da Silva Ribeiro AE, Costa RO, Lucetti DL, Lucetti ECP, Neves KRT, de Barros Viana GS. Neuroprotective effects of valproic acid on brain ischemia are related to its HDAC and GSK3 inhibitions. Pharmacology Biochemistry and Behavior 2018;167:17-28. [DOI: 10.1016/j.pbb.2018.02.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
37 Beurel E, Jope RS. Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits. Transl Psychiatry 2014;4:e488. [PMID: 25514751 DOI: 10.1038/tp.2014.129] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 6.8] [Reference Citation Analysis]
38 Pandey MK, DeGrado TR. Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging. Theranostics 2016;6:571-93. [PMID: 26941849 DOI: 10.7150/thno.14334] [Cited by in Crossref: 102] [Cited by in F6Publishing: 92] [Article Influence: 17.0] [Reference Citation Analysis]
39 L'Episcopo F, Tirolo C, Caniglia S, Testa N, Morale MC, Serapide MF, Pluchino S, Marchetti B. Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease. J Mol Cell Biol 2014;6:13-26. [PMID: 24431301 DOI: 10.1093/jmcb/mjt053] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
40 Parvaneh Tafreshi A, Talebi F, Ghorbani S, Bernard C, Noorbakhsh F. Altered expression of IGF-I system in neurons of the inflamed spinal cord during acute experimental autoimmune encephalomyelitis. J Comp Neurol 2017;525:3072-82. [PMID: 28617951 DOI: 10.1002/cne.24263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
41 Perry BI, Singh S. First-episode psychosis and abnormal glycaemic control – Authors' reply. The Lancet Psychiatry 2017;4:24. [DOI: 10.1016/s2215-0366(16)30411-4] [Reference Citation Analysis]
42 Sekino N, Selim M, Shehadah A. Sepsis-associated brain injury: underlying mechanisms and potential therapeutic strategies for acute and long-term cognitive impairments. J Neuroinflammation 2022;19:101. [PMID: 35488237 DOI: 10.1186/s12974-022-02464-4] [Reference Citation Analysis]
43 Bernstein DL, Zuluaga-Ramirez V, Gajghate S, Reichenbach NL, Polyak B, Persidsky Y, Rom S. miR-98 reduces endothelial dysfunction by protecting blood-brain barrier (BBB) and improves neurological outcomes in mouse ischemia/reperfusion stroke model. J Cereb Blood Flow Metab 2020;40:1953-65. [PMID: 31601141 DOI: 10.1177/0271678X19882264] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
44 Wu YY, Hsieh CT, Chiu YM, Chou SC, Kao JT, Shieh DC, Lee YJ. GSK-3 inhibitors enhance TRAIL-mediated apoptosis in human gastric adenocarcinoma cells. PLoS One 2018;13:e0208094. [PMID: 30557366 DOI: 10.1371/journal.pone.0208094] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
45 Kaidanovich-Beilin O, Beaulieu JM, Jope RS, Woodgett JR. Neurological functions of the masterswitch protein kinase - gsk-3. Front Mol Neurosci 2012;5:48. [PMID: 22509152 DOI: 10.3389/fnmol.2012.00048] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
46 Liu X, Yao Z. Chronic over-nutrition and dysregulation of GSK3 in diseases. Nutr Metab (Lond) 2016;13:49. [PMID: 27493677 DOI: 10.1186/s12986-016-0108-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
47 Zhu L, Xu H, Lv W, He Z, Ye P, Wang Y, Hu J. miR-199b-5p Regulates Immune-Mediated Allograft Rejection after Lung Transplantation Through the GSK3β and NF-κB Pathways. Inflammation 2018;41:1524-35. [PMID: 29779167 DOI: 10.1007/s10753-018-0799-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
48 Garcia-Lacarte M, Mansego ML, Zulet MA, Martinez JA, Milagro FI. miR-1185-1 and miR-548q Are Biomarkers of Response to Weight Loss and Regulate the Expression of GSK3B. Cells 2019;8:E1548. [PMID: 31801236 DOI: 10.3390/cells8121548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
49 Beurel E, Grieco SF, Jope RS. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther 2015;148:114-31. [PMID: 25435019 DOI: 10.1016/j.pharmthera.2014.11.016] [Cited by in Crossref: 692] [Cited by in F6Publishing: 673] [Article Influence: 86.5] [Reference Citation Analysis]
50 Lipina TV, Roder JC. Disrupted-In-Schizophrenia-1 (DISC1) interactome and mental disorders: impact of mouse models. Neurosci Biobehav Rev 2014;45:271-94. [PMID: 25016072 DOI: 10.1016/j.neubiorev.2014.07.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
51 Beurel E, Harrington LE, Jope RS. Inflammatory T helper 17 cells promote depression-like behavior in mice. Biol Psychiatry 2013;73:622-30. [PMID: 23174342 DOI: 10.1016/j.biopsych.2012.09.021] [Cited by in Crossref: 145] [Cited by in F6Publishing: 135] [Article Influence: 14.5] [Reference Citation Analysis]
52 Ahn M, Kim J, Park C, Cho J, Jee Y, Jung K, Moon C, Shin T. Potential involvement of glycogen synthase kinase (GSK)-3β in a rat model of multiple sclerosis: evidenced by lithium treatment. Anat Cell Biol 2017;50:48-59. [PMID: 28417055 DOI: 10.5115/acb.2017.50.1.48] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
53 Serrano FG, Tapia-Rojas C, Carvajal FJ, Hancke J, Cerpa W, Inestrosa NC. Andrographolide reduces cognitive impairment in young and mature AβPPswe/PS-1 mice. Mol Neurodegener 2014;9:61. [PMID: 25524173 DOI: 10.1186/1750-1326-9-61] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 7.5] [Reference Citation Analysis]
54 Li J, Ma S, Chen J, Hu K, Li Y, Zhang Z, Su Z, Woodgett JR, Li M, Huang Q. GSK-3β Contributes to Parkinsonian Dopaminergic Neuron Death: Evidence From Conditional Knockout Mice and Tideglusib. Front Mol Neurosci 2020;13:81. [PMID: 32581704 DOI: 10.3389/fnmol.2020.00081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
55 Iwaloye O, Elekofehinti OO, Oluwarotimi EA, Kikiowo BI, Fadipe TM. Insight into glycogen synthase kinase-3β inhibitory activity of phyto-constituents from Melissa officinalis: in silico studies. In Silico Pharmacol 2020;8:2. [PMID: 32968615 DOI: 10.1007/s40203-020-00054-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
56 Golpich M, Amini E, Hemmati F, Ibrahim NM, Rahmani B, Mohamed Z, Raymond AA, Dargahi L, Ghasemi R, Ahmadiani A. Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease. Pharmacol Res 2015;97:16-26. [PMID: 25829335 DOI: 10.1016/j.phrs.2015.03.010] [Cited by in Crossref: 140] [Cited by in F6Publishing: 139] [Article Influence: 20.0] [Reference Citation Analysis]
57 King MK, Pardo M, Cheng Y, Downey K, Jope RS, Beurel E. Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments. Pharmacol Ther 2014;141:1-12. [PMID: 23916593 DOI: 10.1016/j.pharmthera.2013.07.010] [Cited by in Crossref: 109] [Cited by in F6Publishing: 104] [Article Influence: 12.1] [Reference Citation Analysis]
58 do Vale EM, Xavier CC, Nogueira BG, Campos BC, de Aquino PE, da Costa RO, Leal LK, de Vasconcelos SM, Neves KR, de Barros Viana GS. Antinociceptive and Anti-Inflammatory Effects of Ketamine and the Relationship to Its Antidepressant Action and GSK3 Inhibition. Basic Clin Pharmacol Toxicol 2016;119:562-73. [PMID: 27390215 DOI: 10.1111/bcpt.12637] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
59 Bernstein DL, Gajghate S, Reichenbach NL, Winfield M, Persidsky Y, Heldt NA, Rom S. let-7g counteracts endothelial dysfunction and ameliorating neurological functions in mouse ischemia/reperfusion stroke model. Brain Behav Immun 2020;87:543-55. [PMID: 32017988 DOI: 10.1016/j.bbi.2020.01.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
60 Maes M, Fišar Z, Medina M, Scapagnini G, Nowak G, Berk M. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology 2012;20:127-50. [PMID: 22271002 DOI: 10.1007/s10787-011-0111-7] [Cited by in Crossref: 204] [Cited by in F6Publishing: 200] [Article Influence: 20.4] [Reference Citation Analysis]
61 Wang F, Wang L, Sui G, Yang C, Guo M, Xiong X, Chen Z, Lei P. IGF-1 Alleviates Mitochondrial Apoptosis through the GSK3β/NF-κB/NLRP3 Signaling Pathway in LPS-Treated PC-12 Cells. J Mol Neurosci 2021;71:1320-8. [PMID: 33403593 DOI: 10.1007/s12031-020-01759-6] [Reference Citation Analysis]
62 Tafreshi AP, Payne N, Sun G, Sylvain A, Schulze K, Bernard C. Inactive GSK3β is disturbed in the spinal cord during experimental autoimmune encephalomyelitis, but rescued by stem cell therapy. Neuroscience 2014;277:498-505. [PMID: 25064057 DOI: 10.1016/j.neuroscience.2014.07.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]